Duration of adjuvant chemotherapy for patients with non-metastatic colorectal cancer-Reference-Cited by-同舟云学术

Duration of adjuvant chemotherapy for patients with non-metastatic colorectal cancer

Published:2010-01-20 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Des Guetz Gaëtan¹,Uzzan Bernard²,Morere Jean-Francois¹,Perret Gerard²,Nicolas Patrick²

Affiliation:

1. Hospital Avicenne; Oncology; 125 Rue de Stalingrad Bobigny France 93009

2. Hospital Avicenne; Pharmacology; 125 Rue de Stalingrad Bobigny France 93009

Publisher

Wiley

Subject

Pharmacology (medical)

Reference14 articles.

1. Phase III Study Comparing a Semimonthly With a Monthly Regimen of Fluorouracil and Leucovorin As Adjuvant Treatment for Stage II and III Colon Cancer Patients: Final Results of GERCOR C96.1;André;J Clin Oncol,2007

2. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089;Haller;J Clin Oncol,2005

3. Optimum duration of oral adjuvant chemotherapy of HCFU for colorectal cancer; review of 5-year follow-up.;Ito;Anticancer Res,2000

4. Optimal duration of oral adjuvant chemotherapy with Carmofur in the colorectal cancer patients: the Kansai Carmofur Study Group trial III.;Nakamura;Int J Oncol,2001

5. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer;O'Connell;J Clin Oncol,1998

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrence‐free survival dynamics following adjuvant chemotherapy for resected colorectal cancer: A systematic review of randomized controlled trials;Cancer Medicine;2024-01

2. Comparison of the Efficacy and Safety of 3 Months of CAPOX Followed by 3 Months of Capecitabine and 6 Months of CAPOX/FOLFOX in the Adjuvant Treatment of Low-Risk Stage III Colon Cancer Treated Surgically;Oncology;2023-06-28

3. Pharmacological Mechanism of Pingxiao Formula against Colorectal Cancer;Evidence-Based Complementary and Alternative Medicine;2022-12-20

4. DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer;Clinical and Translational Oncology;2022-09-08

5. Clinical implication of adjuvant chemotherapy according to mismatch repair status in patients with intermediate-risk stage II colon cancer;Yeungnam University Journal of Medicine;2021-12-22